Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001562180-15-000300)

Filing Details

Accession Number:: 0001562180-15-000300
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-04-20 17:08:51
Reporting Period:: 2015-04-16

Filing Date:: 2015-04-20
Accepted Time:: 2015-04-20 17:08:51
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1404281	Tokai Pharmaceuticals Inc	TKAI	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1618273	Lee Kalowski	C/O Tokai Pharmaceuticals, Inc. 255 State Street 6Th Floor Boston MA 02109	Chief Financial Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-04-16	4,567	$13.00	47,779	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The sale reported on this Form 4 was effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock upon vesting.